Literature DB >> 2173544

The effects of concurrent manipulations of cholinergic and noradrenergic systems on neocortical EEG and spatial learning.

P Riekkinen1, J Sirviö, A Valjakka, A Pitkänen, J Partanen, P Riekkinen1.   

Abstract

In the spatial learning test, young animals were divided into three groups receiving saline, scopolamine (0.15 mg/kg), or scopolamine (0.8 mg/kg). Half of the animals in each group were lesioned with DSP-4 to destroy noradrenergic fibers. DSP-4 lesions did not produce any significant impairment alone or in combination with a lower dose of scopolamine (0.15 mg/kg), but they did further augment the scopolamine (0.8 mg/kg)-induced defect. In the electroencephalography (EEG) experiment, both control rats and DSP-4-lesioned rats were recorded after receiving saline, scopolamine (0.15 mg/kg), and scopolamine (0.8 mg/kg) injections. Scopolamine induced a dose- and behavioral state-dependent EEG slowing, whereas DSP-4 lesions did not change either baseline EEG activity or EEG reactivity to scopolamine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173544     DOI: 10.1016/0163-1047(90)91436-f

Source DB:  PubMed          Journal:  Behav Neural Biol        ISSN: 0163-1047


  4 in total

1.  Coactivation of beta-adrenergic and cholinergic receptors enhances the induction of long-term potentiation and synergistically activates mitogen-activated protein kinase in the hippocampal CA1 region.

Authors:  A M Watabe; P A Zaki; T J O'Dell
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Combined treatment with a 5HT1A receptor agonist and a muscarinic acetylcholine receptor antagonist disrupts water maze navigation behavior.

Authors:  M Riekkinen; J Sirviö; T Toivanen; P Riekkinen
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

3.  Noradrenergic hyperactivity in hippocampus after partial denervation: pharmacological, behavioral, and electrophysiological studies.

Authors:  C Dyon-Laurent; A Hervé; S J Sara
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

4.  Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems.

Authors:  Soheil Keihan Falsafi; Alev Deli; Harald Höger; Arnold Pollak; Gert Lubec
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.